September 19, 2024 – Founded in 2016, FITCI Grad Theradaptive is growing again. The company is commercializing a pipeline of therapeutics in the orthopedic space, targeting multiple clinical applications, including spinal fusion, long bone repair, dental repair, osteochondral reconstruction, and peripheral nerve repair. It launched from FITCI’s Metropolitan Court facility with 6 employees during the … Read more
Clients
— Receives New Designation for Treatment of Platelet-Activating Anti-Platelet Factor 4 (PF4) Disorders — Complements FDA Orphan Drug Designation and Fast Track Designation for VLX-1005 Source: Veralox Frederick, MD, Aug. 14, 2024 – Veralox Therapeutics, a clinical-stage biotechnology company developing first-in-class therapies targeting the 12-lipoxygenase (12-LOX) pathway, announced that the European Medicines Agency (EMA) has granted Orphan … Read more
By Anna Eyler Circular business practices revolutionize industries, mitigate environmental impact, minimize waste generation, achieve cost reductions, and drive sustainable innovation for a brighter future. In a circular economy, materials and products are utilized for their maximum lifespan. Cutting-edge innovations from companies like InventWood and Quantum Loophole are shining examples of how local ingenuity will … Read more
Experience the Future in Every Dimension at FITCI’s spectacular launch celebration of Maryland’s EDGE at 321 Ballenger Center Drive in Frederick, Maryland. Join the journey into the future of innovation in Frederick as we unveil our brand-new space designed to inspire innovation, collaboration, and breakthrough discoveries. Highlights include lots of surprises, and tours of our … Read more
Wednesday, January 17th, 2024 – Accredited Biotech/Biomedical investors gathered in Tysons Corner, Virginia, for a private, in-person presentation and dinner featuring FITCI startup client BioSolution Designs, Inc. (BSD), thanks to our ecosystem partner Opus8. Dozens listened while BSD CEO Sam Glickstein shared details about the rising company and its exciting potential both financially and as … Read more
FITCI Grad builds upon an unprecedented three Breakthrough Medical Device designations by the FDA Theradaptive, a leading biopharmaceutical company using protein engineering to create targeted therapeutics, has been awarded a U.S. Department of Defense (DOD) Clinical Trial Award of up to $7.4M with options, subject to FDA approval to begin phase I/II clinical studies. Awarded … Read more
Alison Demarest & Thomas Blake of PACE Life Sciences Retire Congratulations to Alison Demarest & Thomas Blake of PACE Life Sciences on their retirement. This dynamic duo founded Meridian BioGroup in 2007 after nearly a year of planning, offering expert validation, regulatory, and compliance contract services to the biotechnology and pharmaceutical industries. In 2012, their … Read more
CarrTech Corporation performed its human factor trials with local healthcare professionals at FITCI’s Metropolitan Court location May 17th through 28th, moving their all-in-one package filter and hypodermic needle product, F.R.O.G (filter removal of glass), closer to market. This practical testing enlisted 20 study participants with experience using glass ampoule-based medications (i.e., #physicians, #pharmacists, #nurses). The … Read more
KnowledgeNet.ai and LeadLander are thrilled to announce that they have teamed up to make a powerful collaborative solution available for customers in the fields of prospect research and business development. KnowledgeNet.ai, the AI-relationship intelligence tool for business that connects siloed interactions and information, is excited to combine its organization-wide view of past and present contacts … Read more
Sass Magazine, a women’s lifestyle magazine for female decision makers, focuses on a “vibrant and sassy population of women in western Maryland.” Their readers are “professional, career-oriented individuals with a touch of sass!” Each edition spotlights women leading their fields, especially those making strides in traditionally male-dominated professions. The March/April issue highlighted some of this … Read more
